6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,298 / Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01301573 (ClinicalTrials.gov) | January 2011 | 18/2/2011 | Long Term Follow-Up Study for rAAV-GAD Treated Subjects | Parkinson's Disease | Biological: rAAV-GAD | Neurologix, Inc. | NULL | Terminated | 30 Years | 90 Years | Both | 40 | N/A | United States |